Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring
Advanced Materials · 2023
DOI: 10.1002/adma.202307169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Huihui He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, …. Hauptthemen laut MEDLINE: Exoskeleton Device, Mesenchymal Stem Cells, Myocardial Infarction, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal–organic frameworks are generated to produce partial‐coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell‐based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial‐coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin α5β1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial‐coated BMSCs display enhanced cell retention in infarcted myocardium through non‐invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell‐exoskeleton interactions and benefits the rational design and manufacture of next‐generation nanobiohybrids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Engin…
- Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Key Laboratory of Tissue Engineering and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang Province, 310058, Ch…
- Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, 310009, China.
- The First Clinical Medical College, Wenzhou Medical University, Wenzhou, Zhejiang Province, 325035, China.
ORCID-Profile: Huihui He, Mengfei Yu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
He, H., Yuan, Y., Wu, Y., Lu, J., Yang, X., Lu, K., Liu, A., Cao, Z., Sun, M., Yu, M., & Wang, H. (2023). Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring. Advanced Materials. https://doi.org/10.1002/adma.202307169
Vancouver
He H, Yuan Y, Wu Y, Lu J, Yang X, Lu K, et al. Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring. Advanced Materials. 2023. doi:10.1002/adma.202307169
BibTeX
@article{He2023,
author = {He, Huihui and Yuan, Yuan and Wu, Yunhong and Lu, Jingyi and Yang, Xiaofu and Lu, Kejie and Liu, An and Cao, Zelin and Sun, Miao and Yu, Mengfei and Wang, Huiming},
title = {Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202307169}
}
EUVIMED